Last reviewed · How we verify
NCT04776733
Prepackaged Nutritional Formulations Versus Restricted Diet for Bowel Preparation
NA trial testing prepackaged semisolid nutritional formulations in Bowel Preparation in 196 participants. Status unknown.
1 September 2021
Quick facts
| Lead sponsor | Ningbo No. 1 Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | screening |
| Enrollment | 196 |
| Start date | 1 March 2021 |
| Primary completion | 1 September 2021 |
| Estimated completion | 1 October 2021 |
| Sites | 1 location across China |
Drugs / interventions tested
- prepackaged semisolid nutritional formulations
- restricted diet
Conditions studied
- Bowel Preparation — all drugs for Bowel Preparation →
Sponsor
Ningbo No. 1 Hospital
Who can join
Adults 18 to 75, any sex, with Bowel Preparation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In order to analyze the effectiveness and patient tolerance of the two bowel preparation regimens, the investigators will compare prepackaged semisolid nutritional formulations and restricted diet. The aim was to demonstrate that prepackaged semisolid nutritional formulations is not inferior in overall quality of intestinal preparation to restricted diet in subjects undergoing colonoscopy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04776733
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Bowel Preparation
Currently open trials in the same condition.
- NCT06051955 — Evaluation of an Oral Sodium Sulfate Solution for Patients With Prior Difficult or Incomplete Cleansing · NA · recruiting
Other Ningbo No. 1 Hospital trials
Trials by the same sponsor.
- NCT07181759 — Clinical Trial of VISOR vs fURS for Upper Urinary Tract Stone · NA · not yet recruiting
- NCT07001865 — Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia · enrolling by invitation
- NCT06984510 — Accelerated Biological Aging is Associated With Increased Risk of T2DM in the MASLD Population · recruiting
- NCT06905795 — Screening and Intervention of MASLD in Children · NA · active not recruiting
- NCT06987760 — Comparing Different Diameter fURSs With Similar RESDs for the Treatment of Upper Urinary Tract Stones · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04776733 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ningbo No. 1 Hospital
- Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04776733.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing